ParoliniO, AlvianoF, BagnaraGP, BilicG, BuhringHJ, EvangelistaM, HennerbichlerS, LiuB, MagattiMet al.2008. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells, 26:300–311.
2.
HuangYC, YangZM, ChenXH, TanMY, WangJ, LiXQ, XieHQ, DengL. 2009. Isolation of mesenchymal stem cells from human placental decidua basalis and resistance to hypoxia and serum deprivation. Stem Cell Rev, 5:247–255.
3.
TroyerDL, WeissML. 2008. Wharton's jelly-derived cells are a primitive stromal cell population. Stem Cells, 26:591–599.
4.
BiebackK, KernS, KluterH, EichlerH. 2004. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells, 22:625–634.
5.
La RoccaG. 2011. Connecting the dots: the promises of Wharton's jelly mesenchymal stem cells for tissue repair and regeneration. Open Tissue Eng Regen Med J, 4:3–5.
CanA, KarahuseyinogluS. 2007. Concise review: human umbilical cord stroma with regard to the source of fetus-derived stem cells. Stem Cells, 25:2886–2895.
8.
La RoccaG, AnzaloneR, FarinaF. 2009. The expression of CD68 in human umbilical cord mesenchymal stem cells: new evidences of presence in non-myeloid cell types. Scand J Immunol, 70:161–162.
9.
BakshD, YaoR, TuanRS. 2007. Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells, 25:1384–1392.
10.
SarugaserR, LickorishD, BakshD, HosseiniMM, DaviesJE. 2005. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells, 23:220–229.
11.
VidalMA, WalkerNJ, NapoliE, BorjessonDL. 2012. Evaluation of senescence in mesenchymal stem cells isolated from equine bone marrow, adipose tissue, and umbilical cord tissue. Stem Cells Dev, 21:273–283.
12.
FongCY, RichardsM, ManasiN, BiswasA, BongsoA. 2007. Comparative growth behaviour and characterization of stem cells from human Wharton's jelly. Reprod Biomed Online, 15:708–718.
FongCY, ChakLL, BiswasA, TanJH, GauthamanK, ChanWK, BongsoA. 2011. Human Wharton's jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev, 7:1–16.
15.
AnzaloneR, Lo IaconoM, CorraoS, MagnoF, LoriaT, CappelloF, ZummoG, FarinaF, La RoccaG. 2010. New emerging potentials for human Wharton's jelly mesenchymal stem cells: immunological features and hepatocyte-like differentiative capacity. Stem Cells Dev, 19:423–438.
16.
AnzaloneR, Lo IaconoM, LoriaT, Di StefanoA, GiannuzziP, FarinaF, La RoccaG. 2011. Wharton's jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the differentiative and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes. Stem Cell Rev, 7:342–363.
17.
La RoccaG, AnzaloneR, CorraoS, MagnoF, LoriaT, Lo IaconoM, Di StefanoA, GiannuzziPet al.2009. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol, 131:267–282.
18.
Lo IaconoM, AnzaloneR, CorraoS, GiuffrM, Di StefanoA, GiannuzziP, CappelloF, FarinaF, La RoccaG. 2011. Perinatal and Wharton's jelly-derived mesenchymal stem cells in cartilage regenerative medicine and tissue engineering strategies. Open Tissue Eng Regen Med J, 4:72–81.
19.
NekantiU, MohantyL, VenugopalP, BalasubramanianS, ToteyS, TaM. 2010. Optimization and scale-up of Wharton's jelly-derived mesenchymal stem cells for clinical applications. Stem Cell Res, 5:244–254.
20.
De BruynC, NajarM, RaicevicG, MeulemanN, PietersK, StamatopoulosB, DelforgeA, BronD, LagneauxL. 2011. A rapid, simple, and reproducible method for the isolation of mesenchymal stromal cells from Wharton's jelly without enzymatic treatment. Stem Cells Dev, 20:547–557.
21.
SeccoM, MoreiraYB, ZucconiE, VieiraNM, JazedjeT, MuotriAR, OkamotoOK, Verjovski-AlmeidaS, ZatzM. 2009. Gene expression profile of mesenchymal stem cells from paired umbilical cord units: cord is different from blood. Stem Cell Rev, 5:387–401.
22.
CavalloC, CuomoC, FantiniS, RicciF, TazzariPL, LucarelliE, DonatiD, FacchiniA, LisignoliGet al.2011. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies. J Cell Biochem, 112:1418–1430.
23.
HsiehJY, FuYS, ChangSJ, TsuangYH, WangHW. 2010. Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev, 19:1895–1910.
24.
SubramanianA, Shu-UinG, Kae-SiangN, GauthamanK, BiswasA, ChoolaniM, BongsoA, Chui-YeeF. 2012. Human umbilical cord Wharton's jelly mesenchymal stem cells do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells unlike bone marrow mesenchymal stem cells. J Cell Biochem, 113:1886–1895.
25.
WuKH, ChanCK, TsaiC, ChangYH, SieberM, ChiuTH, HoM, PengCT, WuHP, HuangJL. 2011. Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells. Transplantation, 91:1412–1416.
26.
SunL, WangD, LiangJ, ZhangH, FengX, WangH, HuaB, LiuB, YeSet al.2010. Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum, 62:2467–2475.
27.
DominiciM, Le BlancK, MuellerI, Slaper-CortenbachI, MariniF, KrauseD, DeansR, KeatingA, ProckopD, HorwitzE. 2006. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:315–317.
28.
BoschJ, HoubenAP, RadkeTF, StapelkampD, BunemannE, BalanP, BuchheiserA, LiedtkeS, KoglerG. 2012. Distinct differentiation potential of “msc” derived from cord blood and umbilical cord: are cord-derived cells true mesenchymal stromal cells?Stem Cells Dev[Epub ahead of print]10.1089/scd.2011.0414.
29.
FongCY, SubramanianA, GauthamanK, VenugopalJ, BiswasA, RamakrishnaS, BongsoA. 2012. Human umbilical cord Wharton's jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment. Stem Cell Rev, 8:195–209.
30.
AnzaloneR, FarinaF, ZummoG, La RoccaG. 2011. Recent patents and advances on isolation and cellular therapy applications of mesenchymal stem cells from human umbilical cord Wharton's jelly. Recent Pat Regen Med, 1:216–227.
31.
KitaK, GauglitzGG, PhanTT, HerndonDN, JeschkeMG. 2010. Isolation and characterization of mesenchymal stem cells from the sub-amniotic human umbilical cord lining membrane. Stem Cells Dev, 19:491–502.
32.
JeschkeMG, GauglitzGG, PhanTT, HerndonDN, KitaK. 2011. Umbilical cord lining membrane and Wharton's jelly-derived mesenchymal stem cells: the similarities and differences. Open Tissue Eng Regen Med J, 4:21–27.
